Titre : Benzofuranes

Benzofuranes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzofuranes : Questions médicales les plus fréquentes", "headline": "Benzofuranes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzofuranes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-05", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzofuranes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérobicycliques", "url": "https://questionsmedicales.fr/mesh/D006574", "about": { "@type": "MedicalCondition", "name": "Composés hétérobicycliques", "code": { "@type": "MedicalCode", "code": "D006574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amiodarone", "alternateName": "Amiodarone", "url": "https://questionsmedicales.fr/mesh/D000638", "about": { "@type": "MedicalCondition", "name": "Amiodarone", "code": { "@type": "MedicalCode", "code": "D000638", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.075" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dronédarone", "alternateName": "Dronedarone", "url": "https://questionsmedicales.fr/mesh/D000077764", "about": { "@type": "MedicalCondition", "name": "Dronédarone", "code": { "@type": "MedicalCode", "code": "D000077764", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.075.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Benzbromarone", "alternateName": "Benzbromarone", "url": "https://questionsmedicales.fr/mesh/D001553", "about": { "@type": "MedicalCondition", "name": "Benzbromarone", "code": { "@type": "MedicalCode", "code": "D001553", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.110" } } }, { "@type": "MedicalWebPage", "name": "Cantharidine", "alternateName": "Cantharidin", "url": "https://questionsmedicales.fr/mesh/D002193", "about": { "@type": "MedicalCondition", "name": "Cantharidine", "code": { "@type": "MedicalCode", "code": "D002193", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.125" } } }, { "@type": "MedicalWebPage", "name": "Citalopram", "alternateName": "Citalopram", "url": "https://questionsmedicales.fr/mesh/D015283", "about": { "@type": "MedicalCondition", "name": "Citalopram", "code": { "@type": "MedicalCode", "code": "D015283", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.187" } } }, { "@type": "MedicalWebPage", "name": "Escitalopram", "alternateName": "Escitalopram", "url": "https://questionsmedicales.fr/mesh/D000089983", "about": { "@type": "MedicalCondition", "name": "Escitalopram", "code": { "@type": "MedicalCode", "code": "D000089983", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.203" } } }, { "@type": "MedicalWebPage", "name": "Fura-2", "alternateName": "Fura-2", "url": "https://questionsmedicales.fr/mesh/D016257", "about": { "@type": "MedicalCondition", "name": "Fura-2", "code": { "@type": "MedicalCode", "code": "D016257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.250" } } }, { "@type": "MedicalWebPage", "name": "Griséofulvine", "alternateName": "Griseofulvin", "url": "https://questionsmedicales.fr/mesh/D006118", "about": { "@type": "MedicalCondition", "name": "Griséofulvine", "code": { "@type": "MedicalCode", "code": "D006118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.127.275" } } } ], "about": { "@type": "MedicalCondition", "name": "Benzofuranes", "alternateName": "Benzofurans", "code": { "@type": "MedicalCode", "code": "D001572", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Zhi Xu", "url": "https://questionsmedicales.fr/author/Zhi%20Xu", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, Guizhou, P.R. China." } }, { "@type": "Person", "name": "Wei Zhou", "url": "https://questionsmedicales.fr/author/Wei%20Zhou", "affiliation": { "@type": "Organization", "name": "School of Pharmacy, Guizhou Medical University, Guiyang 550025, Guizhou, P.R. China." } }, { "@type": "Person", "name": "Ashraf A Abbas", "url": "https://questionsmedicales.fr/author/Ashraf%20A%20Abbas", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602." } }, { "@type": "Person", "name": "Kamal M Dawood", "url": "https://questionsmedicales.fr/author/Kamal%20M%20Dawood", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Faculty of Science, Cairo University Giza 12613 Egypt kmdawood@sci.cu.edu.eg +20-2-35727556 +20-2-35676602." } }, { "@type": "Person", "name": "Giovanni Luca Beretta", "url": "https://questionsmedicales.fr/author/Giovanni%20Luca%20Beretta", "affiliation": { "@type": "Organization", "name": "Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133 Milan, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36097245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17269/s41997-022-00691-z" } }, { "@type": "ScholarlyArticle", "name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075336" } }, { "@type": "ScholarlyArticle", "name": "Global pen pal education intervention among student pharmacists: A pilot project.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36153244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2022.09.020" } }, { "@type": "ScholarlyArticle", "name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39457265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21101292" } }, { "@type": "ScholarlyArticle", "name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36798046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231157833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzofuranes", "item": "https://questionsmedicales.fr/mesh/D001572" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzofuranes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzofuranes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzofuranes", "description": "Comment diagnostiquer une intoxication aux benzofuranes ?\nQuels tests sont utilisés pour détecter les benzofuranes ?\nQuels symptômes indiquent une exposition aux benzofuranes ?\nLes benzofuranes sont-ils visibles sur des tests standards ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzofuranes", "description": "Quels sont les symptômes courants des benzofuranes ?\nLes benzofuranes provoquent-ils des effets psychologiques ?\nY a-t-il des symptômes cutanés associés aux benzofuranes ?\nLes benzofuranes affectent-ils le système respiratoire ?\nLes symptômes varient-ils selon la dose de benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzofuranes", "description": "Comment prévenir l'exposition aux benzofuranes ?\nLes travailleurs doivent-ils être formés sur les benzofuranes ?\nQuelles mesures de sécurité sont recommandées en laboratoire ?\nLes benzofuranes sont-ils réglementés ?\nComment gérer les déchets contenant des benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzofuranes", "description": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?\nDes antidotes existent-ils pour les benzofuranes ?\nComment traiter les symptômes neurologiques causés par les benzofuranes ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?\nLa décontamination est-elle nécessaire après exposition ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzofuranes", "description": "Quelles complications peuvent survenir après exposition aux benzofuranes ?\nLes benzofuranes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des benzofuranes ?\nLes benzofuranes peuvent-ils affecter la reproduction ?\nComment surveiller les complications liées aux benzofuranes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzofuranes", "description": "Qui est à risque d'exposition aux benzofuranes ?\nLes benzofuranes sont-ils présents dans des produits courants ?\nL'âge influence-t-il la sensibilité aux benzofuranes ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes benzofuranes affectent-ils différemment les sexes ?", "url": "https://questionsmedicales.fr/mesh/D001572?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux benzofuranes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et les tests toxicologiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les benzofuranes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux benzofuranes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des nausées et des palpitations." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils visibles sur des tests standards ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, des tests spécifiques sont nécessaires pour détecter les benzofuranes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux benzofuranes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des benzofuranes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des vertiges, des maux de tête et des troubles de la vision." } }, { "@type": "Question", "name": "Les benzofuranes provoquent-ils des effets psychologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent causer de l'anxiété, des hallucinations et des troubles de l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cutanés associés aux benzofuranes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées et des démangeaisons peuvent survenir après exposition." } }, { "@type": "Question", "name": "Les benzofuranes affectent-ils le système respiratoire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent provoquer des difficultés respiratoires et une irritation des voies respiratoires." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose de benzofuranes ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux benzofuranes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection et suivre les protocoles de sécurité en laboratoire." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les benzofuranes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Quelles mesures de sécurité sont recommandées en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée en raison de leur toxicité potentielle." } }, { "@type": "Question", "name": "Comment gérer les déchets contenant des benzofuranes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les déchets doivent être éliminés selon les protocoles de gestion des déchets dangereux." } }, { "@type": "Question", "name": "Quel traitement est recommandé pour l'intoxication aux benzofuranes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les benzofuranes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les benzofuranes." } }, { "@type": "Question", "name": "Comment traiter les symptômes neurologiques causés par les benzofuranes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour gérer les symptômes neurologiques." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires pour l'exposition aux benzofuranes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins d'urgence peuvent être nécessaires en cas d'exposition sévère." } }, { "@type": "Question", "name": "La décontamination est-elle nécessaire après exposition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la décontamination est essentielle pour réduire l'absorption des benzofuranes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition aux benzofuranes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, respiratoires et dermatologiques peuvent survenir." } }, { "@type": "Question", "name": "Les benzofuranes peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme des benzofuranes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires." } }, { "@type": "Question", "name": "Les benzofuranes peuvent-ils affecter la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Comment surveiller les complications liées aux benzofuranes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est recommandé pour détecter les complications précoces." } }, { "@type": "Question", "name": "Qui est à risque d'exposition aux benzofuranes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs en laboratoire et ceux manipulant des produits chimiques sont à risque." } }, { "@type": "Question", "name": "Les benzofuranes sont-ils présents dans des produits courants ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être présents dans certains produits chimiques et médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité aux benzofuranes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les benzofuranes affectent-ils différemment les sexes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent que les effets peuvent varier entre les sexes, mais les données sont limitées." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.

Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro... An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p... A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple... This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...

Global pen pal education intervention among student pharmacists: A pilot project.

Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim... This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm... In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...

Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.

In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan... Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and... The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...

Community-supported teaching on the topic of transgender identity in undergraduate medical education - a pilot project.

Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab... During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ... The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga... One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...

Assessing tenant health amid social housing redevelopment: lessons from a pilot project.

To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th... Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,... A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported.... This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...

Developing a trigger tool to monitor adverse events during haemodialysis in children: a pilot project.

We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events.... Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a... There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions... This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...

vSEMERA: pilot project assessing health profession students' experiences in an international virtual research program.

The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho... vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a... The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche... vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...